Skip to main content
Premium Trial:

Request an Annual Quote

Roche, Horizon Ink IHC Reference Standard Development Deal

NEW YORK (GenomeWeb) – Horizon Discovery announced today that it has entered an agreement with Roche Diagnostics to develop immunohistochemistry reference standards for oncology assays.

The company will develop and provide reference standard material for neurotrophic tropomyosin receptor kinase (NTRK) fusion biomarkers. Effective use of compounds against fusion proteins resulting from NTRK gene rearrangements depends on accurate genotyping of patients, Horizon noted in a statement, and this is typically done using immunohistochemistry.

The company will use gene editing to develop knock-ins of NTRK 1, 2, and 3 fusion cDNA under the control of multiple promoters to achieve low to high levels of protein expression in cell lines, and cells will be provided in a formalin-fixed paraffin embedded format to mimic patient samples.

The new agreement builds on a previous partnership with Roche subsidiary Ventana Medical Systems to develop, manufacture, and commercialize cell line derivative material for use as reference standards in cancer tissue diagnostics.

Horizon has established a number of partnerships recently with firms including Fulcrum Therapeutics, Sophia Genetics, and CareDx.

The Scan

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.

Study Finds Variants Linked to Diverticular Disease, Presents Polygenic Score

A new study in Cell Genomics reports on more than 150 genetic variants associated with risk of diverticular disease.

Mild, Severe Psoriasis Marked by Different Molecular Features, Spatial Transcriptomic Analysis Finds

A spatial transcriptomics paper in Science Immunology finds differences in cell and signaling pathway activity between mild and severe psoriasis.

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.